What is the expected market price of pomalidomide in 2025?

Pomalidomide (Pomalidomide) is a classic immunomodulator that is primarily used to treat multiple myeloma, especially in patients whose disease has progressed despite other treatments. Its mechanism of action is mainly to achieve therapeutic effects by enhancing the anti-tumor response of the immune system, inhibiting the growth of tumor cells, and inducing apoptosis of tumor cells. In recent years, pomalidomide has been approved for marketing in China and has been successfully included in medical insurance, which greatly facilitates patients who need long-term treatment.

Although pomalidomide has been marketed in China, patients have to face a common problem when receiving treatment, which is the high price of the drug. According to the policies of different regions and hospitals, the price after medical insurance reimbursement will be different. Therefore, it is recommended that patients consult the local hospital pharmacy when seeking medical treatment to obtain more accurate information. On the one hand, this enables some patients to obtain financial support; on the other hand, it also reflects the complexity and diversity of drug prices in my country's medical system.

In addition to domestic pomalidomide, there are also overseas generic versions on the market, such as generic drugs in Laos, which are relatively affordable at about more than 300 yuan. Although this option is attractive in terms of price, patients still need to be careful when choosing to ensure the quality and efficacy of the medicine. In addition, since pomalidomide is a prescription drug, patients must strictly follow their doctor's instructions before use to avoid potential adverse reactions and drug interactions.

In summary, the application of pomalidomide provides a new treatment option for patients with multiple myeloma, especially after other treatments have failed. With the coverage of medical insurance, more patients are expected to receive this effective treatment. However, drug prices are still an important factor affecting patients' treatment choices. It is recommended that patients make informed decisions based on their own circumstances after understanding the relevant information.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide